Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Yield10 Bioscience Inc logo

Yield10 Bioscience Inc (YTEN)

Market Closed
1 Apr, 20:00
OTC PINK OTC PINK
$
0. 01
0
0%
$
939.74K Market Cap
- P/E Ratio
0% Div Yield
250 Volume
-0.75 Eps
$ 0.01
Previous Close
Day Range
0.01 0.01
Year Range
0 7.16
Want to track YTEN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Earnings results expected in 51 days

Summary

YTEN closed Tuesday higher at $0.01, an increase of 0% from Monday's close, completing a monthly increase of 0% or $0. Over the past 12 months, YTEN stock lost -92.57%.
YTEN is not paying dividends to its shareholders.
The last earnings report, released on May 13, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 1.57%, based on the last three reports. The next scheduled earnings report is due on Aug 12, 2025.
Yield10 Bioscience Inc has completed 4 stock splits, with the recent split occurring on May 03, 2024.
The company's stock is traded on 0 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

YTEN Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
No Data
End of interactive chart.
Yield10 Bioscience Announces Adjournment of Special Meeting of Stockholders to Solicit Sufficient Votes in Favor of the Key Proposals

Yield10 Bioscience Announces Adjournment of Special Meeting of Stockholders to Solicit Sufficient Votes in Favor of the Key Proposals

Special Meeting Adjourned to Thursday, November 21, 2024  WOBURN, MA / ACCESSWIRE / November 8, 2024 / Yield10 Bioscience, Inc. (OTCQB:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today announced that its Special Meeting of Stockholders (the "Special Meeting"), scheduled to be held at 11:00 a.m., Eastern Time, on November 8, 2024, was convened and adjourned, without any business being conducted, due to lack of sufficient votes in favor of the key proposals related to the Asset Sale to Nuseed and the Dissolution proposal.

Accesswire | 7 months ago
Yield10 Bioscience Announces Second Quarter 2024 Financial Results

Yield10 Bioscience Announces Second Quarter 2024 Financial Results

WOBURN, Mass., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today reported financial results for the second quarter ended June 30, 2024.

Globenewswire | 10 months ago
Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets

Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets

WEST SACRAMENTO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company has signed a Memorandum of Understanding (“MOU”) and License Agreement with Nuseed Nutritional US Inc. (the seed technologies platform of Nufarm Limited (ASX:NUF)), granting Nufarm a commercial license to certain Omega-3 intellectual property assets, materials and know-how for producing oil in Camelina.

Globenewswire | 11 months ago

Yield10 Bioscience Inc (YTEN) FAQ

What is the stock price today?

The current price is $0.01.

On which exchange is it traded?

Yield10 Bioscience Inc is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is YTEN.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 939.74K.

When is the next earnings date?

The next earnings report will release on Aug 12, 2025.

Has Yield10 Bioscience Inc ever had a stock split?

Yield10 Bioscience Inc had 4 splits and the recent split was on May 03, 2024.

Yield10 Bioscience Inc Profile

Agricultural Inputs Industry
Basic Materials Sector
Dr. Oliver P. Peoples Ph.D. CEO
OTC PINK Exchange
US98585K8624 ISIN
United States Country
29 Employees
- Last Dividend
16 Jan 2020 Last Split
10 Nov 2006 IPO Date
Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.

Contact Information

Address: 19 Presidential Way
Phone: (617) 583-1700
Affiliate Program About Report a Bug Terms Privacy Help Contact Us
2025 © Marketlog. All Rights Reserved.
Play store app banner Play store app banner dark App store app banner App store app banner dark
Logo Logo
Sign Up
Sign In